What Is the Role of PK/PD Studies in Biosimilar Development and Can They Replace Clinical Efficacy Trials?
Introduction: The role of PK/PD studies in biosimilar development has become one of the most closely watched questions in biologics […]
Peptide Impurity Identification and Characterization Services: Process-Related and Degradation Impurities
Introduction: Advanced Advancements in Peptide Impurity Identification and Characterization Services Peptide Impurity Identification and Characterization Services are specialized analytical solutions
Residual Solvent Control in PLGA Microsphere Manufacturing: ICH Q3C Limits and Analytical Testing Requirements
Introduction Effective Residual Solvent Control in PLGA Microsphere Manufacturing relies on optimizing post-formulation solvent removal processes and confirming regulatory compliance
Nitrosamine Testing for Injectable Drug Products: Parenteral Formulation Challenges and Regulatory Requirements
Introduction Nitrosamine Testing for Injectable Drug Products is a highly specialized analytical quality control procedure used to identify and quantify
Nitrosamine Testing for Proton Pump Inhibitors: Drug-Class-Specific Risk Factors and CRO Services
Introduction: Nitrosamine testing for proton pump inhibitors has become a non-negotiable part of regulatory compliance for manufacturers of omeprazole, esomeprazole,
Oligonucleotide Bioanalytical Services: Analytical Challenges, Platforms, and CRO Capabilities
Introduction Oligonucleotide Bioanalytical Services refer to specialized qualitative and quantitative analytical testing used to characterize pharmacokinetic (PK), pharmacodynamic (PD), and
Extractables & Leachables (E&L) Testing for Auto-Injectors and Wearable Drug Delivery Devices
Introduction Extractables & Leachables (E&L) Testing for Auto-Injectors involves the specialized chemical characterization and surveillance of substances that migrate from
Reference Product Selection and Sourcing Strategy for Biosimilar Comparability Studies
Introduction: Establishing structural and functional similarity to an approved innovator biologic represents the cornerstone of regulatory approval for biosimilar products
Reference Product Selection and Sourcing Strategy for Biosimilar Comparability Studies Read More »
Bioanalytical CRO for Oncology Clinical Trials: Complex Matrices, PD Biomarkers, and Regulatory Expectations
Bioanalytical CRO for Oncology Clinical Trials: Complex Matrices, PD Biomarkers, and Regulatory Expectations Within the highly specialized field of oncology
Nitrosamine Testing for Injectable Drug Products: Parenteral Formulation Challenges and Regulatory Requirements
Introduction: Implementation of Nitrosamine Testing for Injectable Drug Products is a critical safety and regulatory requirement because parenteral drug products